Long-acting prodrugs of entecavir, preparing methods and uses thereof
US11292811B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2018 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Sep 29, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a long-acting prodrug of Entecavir, preparation method and use thereof, wherein the prodrug of Entecavir has a structure of formula I. The prodrug of Entecavir can be released slowly, sustainably and steady, and converted to active compound of Entecavir to achieve a long-acting effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.